U.S. Trauma Fixation Devices Market Size & Share 2025 - 2034

U.S. Trauma Fixation Devices Market Size

The U.S. trauma fixation devices market size was valued at USD 4.7 billion in 2024. The market is expected to reach from USD 4.8 billion in 2025 to USD 6.2 billion in 2034, growing at a CAGR of 2.8% during the forecast period, according to the latest report published by Global Market Insights Inc.

The high market growth is attributed to the ongoing advancements in trauma fixation technology, rising incidence of orthopedic injuries and accidents, growing geriatric population, surging demand for surgical intervention, and rising sports participation and injuries, among other contributing factors.
 

Trauma fixation devices are medical implants and instruments used to stabilize and heal broken bones and fractures. They comprise a variety of products such as plates, screws, rods, pins, and external fixators, which are used to surgically stabilize bone fragments during the recuperation period. They help maintain bone fragments in proper position so that the fractures heal properly and are crucial in orthopedic procedures that involve realigning and stabilizing bones after traumatic injuries.
 

Leading players in the U.S. trauma fixation devices market include Johnson & Johnson, Stryker, Smith+Nephew, Zimmer Biomet, and INTEGRA. These companies maintain their competitive edge through continuous product innovation, global market presence, and significant investments in research and development.
 

The market has increased from USD 4.3 billion in 2021 and reached USD 4.6 billion in 2023, with the historic growth rate of 3%. Market expansion was supported by the increasing incidences of fractures stemming from accidents, sports injuries, and degenerative bone conditions among the aging population.
 

The U.S. experiences a high volume of road accidents, sports injuries, and workplace trauma annually. According to the National Highway Traffic Safety Administration (NHTSA), there were 42,939 traffic fatalities in 2021, followed by 42,795 deaths in 2022. The Bureau of Labor Statistics reported 2.8 million nonfatal workplace injuries in 2022, with 0.9 million cases resulting in lost workdays.
 

Additionally, the National Safety Council documented that sports-related injuries accounted for 3.2 million emergency department visits in 2022. These incidents frequently result in fractures and musculoskeletal injuries, increasing the demand for trauma fixation devices. The growing number of orthopedic trauma cases requires hospitals and surgical centers to use advanced fixation solutions for effective fracture management.
 

Furthermore, innovations like bioresorbable implants, minimally invasive fixation systems, and 3D-printed implants are improving patient outcomes and reducing recovery time. These advanced devices are being widely adopted in the U.S., fueling market growth. Hospitals are increasingly favoring devices with better biomechanical stability and reduced surgical complications.
 

U.S. Trauma Fixation Devices Market Trends

The U.S. trauma fixation devices industry is experiencing several notable trends that are shaping its growth and development. Factors such as growing shift toward minimally invasive fixation procedures, rising adoption of bioresorbable and biodegradable implants, integration of 3D printing and customization, and growing focus on outpatient and ambulatory surgical centers, among other factors are collectively driving industry growth.
 

• Surgeons in the U.S. are adopting advanced techniques for fixation that are less invasive and minimize tissue damage and post-surgical complications. Devices designed for percutaneous or small-incision surgeries are gaining traction, driven by patient demand for quicker recovery, shorter hospital stays, and improved cosmetic outcomes.
   
• The U.S. is also witnessing a transition in trauma fixation procedures from traditional hospitals to ambulatory surgical centers (ASCs). According to CMS data, ASC procedures increased by 15% in 2022 compared to 2021, with orthopedic procedures accounting for 30% of this growth.
   
• This shift is fueled by cost savings of 40–60% compared to hospital settings, procedure times reduced by 25%, and patient satisfaction rates of 92% in ASCs versus 70% in hospitals (Medicare Payment Advisory Commission Report, 2023). In response, device manufacturers are adapting their portfolios to ASC requirements, with ASC-specific trauma fixation devices growing by 25% in market share between 2022 and 2023.
   
• Further, some of the major U.S. orthopedic device manufacturers are pursuing mergers and collaborations in order to expand the trauma fixation product lines. This approach improves access to new orthopedic innovations and advanced surgical techniques, expands marketing distribution, and increases the share of the market served. The increased competition is also accelerating product development and regulatory approvals, sustaining long-term market growth.
   

U.S. Trauma Fixation Devices Market Analysis

The U.S. trauma fixation devices market was valued at USD 4.3 billion in 2021. The market size reached USD 4.6 billion in 2023, from USD 4.4 billion in 2022.
 

Based on the product, the U.S. trauma fixation devices industry is segmented into internal fixators and external fixators. The internal fixators segment has asserted its dominance in the market by securing a significant market share of 65.1% in 2024 owing to the rising burden of complex fractures and degenerative bone conditions, which require stable and long-term fixation. The segment is expected to exceed USD 4 billion by 2034, growing at a CAGR of 2.6% during the forecast period.
 

On the other hand, the external fixators segment is expected to grow with a CAGR of 3.2%. The growth of this segment is driven by their effectiveness in managing severe open fractures, complex trauma, and emergency cases where immediate stabilization is required. Their versatility in adjusting alignment during healing and reduced invasiveness compared to internal surgery enhance their clinical demand.
 

• The internal fixators segment continues to dominate the market. Internal fixators, such as plates, screws, and intramedullary nails, are the preferred choice for managing complex or unstable fractures. The U.S. records numerous high-impact injuries from road accidents, sports, and falls, creating strong demand for these devices. Their ability to provide stable fixation and faster functional recovery drives adoption.
   
• Additionally, the elderly population in the U.S. suffers from osteoporosis and low bone density and, therefore, experiences a high incidence of hip, wrist, and vertebral fractures. The National Osteoporosis Foundation reported that in the year 2022, 54 million Americans aged 50 and above were estimated to have osteoporosis and low bone mass.
   
• The Centers for Disease Control and Prevention (CDC) reported that hip fractures among the elderly resulted in over 300,000 hospital stays in 2021. These internal fixators are necessary for providing the patients with essential stability for their weakened bones.
   
• The U.S. Census Bureau projects that by 2024, approximately 17.5% of the population in the U.S. will be 65 years or older. This will lead to a higher number of surgical procedures and increase the demand for internal fixation devices.
   
• The external fixators segment held a revenue of USD 1.6 billion in 2024, with projections indicating a steady expansion at 3.2% CAGR from 2025 to 2034. The external fixators are increasingly used for the management of complex open fractures, polytrauma, and limb lengthening where urgent stabilization is needed. They are highly useful in trauma care due to their quick application in emergency situations.
   
• Surgeons also prefer external fixators for complex fractures with high infection risks, as they avoid extensive internal hardware placement. Additionally, technological advancements, such as modular frames and hybrid fixators, are expanding their clinical applications and improving patient outcomes.
   

Based on material, the U.S. trauma fixation devices market is segmented into stainless steel, titanium, and other materials. The stainless steel segment dominated the market in 2024, accounting for USD 2.4 billion and is anticipated to grow at a CAGR of 2.3% during the forecast period.
 

• Stainless steel implants are significantly more affordable than titanium and bioresorbable implants. Even with insurance coverage, stainless steel fixators are popular in America because of their low cost. Their lower price point makes them attractive for both healthcare providers and patients.
   
• Stainless Steel offers exceptional strength and fatigue resistance, especially for load bearing fractures in the femur, tibia, and pelvis. It is capable of reliably holding parts together in high-stress trauma scenarios because it can endure harsh forces without permanent change. This advantage helps sustain its demand across trauma centers.
   
• The titanium segment accounted for significant revenue in 2024 and is anticipated to grow at a CAGR of 3.4% over the forecast period. This segment is driven by the power of biocompatibility and corrosion resistance of titanium that reduces rejection risks and improves patient safety. The titanium’s light weight and high strength are an advantage since it provides better patient comfort and durable fixation.
   
• Titanium implants enhance osseointegration, which improves the rate of bone healing and ensures stability in the long term. In addition, an increasing preference for titanium due to the new demand for stainless steel-free, advanced, MRI-compatible materials is contributing to the growth of this segment.
   

Based on site, the U.S. trauma fixation devices market is segmented into lower extremities and upper extremities. The lower extremities segment dominated the market in 2024, accounting for USD 2.8 billion and is anticipated to grow at a CAGR of 1.9% during the forecast period.
 

• Fractures of the femur, tibia, fibula, ankle, and hip are among the most common trauma cases in the U.S. due to falls, sports injuries, and road accidents. These injuries often require surgical intervention using fixation devices such as plates, screws, and intramedullary nails. The high case volume directly drives demand for lower extremity fixation solutions.
   
• In addition, older adults are especially prone to hip, knee, and ankle fractures due to osteoporosis and reduced mobility. In the U.S., the rising geriatric population significantly contributes to the growing need for lower extremity fixation procedures. The complexity of fractures in this age group makes fixation devices essential for recovery and mobility restoration.
   
• The upper extremities segment accounted for significant revenue in 2024 and is anticipated to grow at a CAGR of 3.9% over the forecast period. Owing to the rising incidence of fractures in the wrist, hand, and shoulder from falls, sports, and road accidents. The increasing aging population, prone to osteoporotic fractures, further boosts demand in this segment.
   
• Advancements in fixation devices tailored for small bones and joints are improving surgical precision and patient outcomes. Additionally, the growing preference for minimally invasive and outpatient procedures in upper extremity trauma care is accelerating adoption.
   

Learn more about the key segments shaping this market

Download Free PDF

Based on end use, the U.S. trauma fixation devices market is classified into orthopedic centers, hospitals, ambulatory surgical centers, and other end users. The orthopedic centers segment dominated the market with a revenue share of 42.7% in 2024 and is expected to reach USD 2.6 billion within the forecast period.
 

• The three largest segments account for over 92% of the total market value, with orthopedic centers holding the highest share. In the U.S., orthopedic centers focus specifically on the management and treatment of musculoskeletal disorders, making them the focal point for trauma fixation procedures. Their specialized skills in managing complicated fractures and fixation devices strongly drive them as market growth factors.
   
• Moreover, these centers have modern equipment like minimally invasive surgical devices, robotic systems, and 3D imaging. These features encourage the use of modern trauma fixation devices. Patients are attracted to these centers because of modern surgical possibilities, and this increases the use of devices.
   
• The hospitals segment held a revenue of USD 1.5 billion in 2024, with projections indicating a steady expansion at 2.2% CAGR from 2025 to 2034. Hospitals act as a major driver due to their advanced infrastructure and ability to handle high volumes of trauma cases. They are the primary setting for complex surgeries requiring internal and external fixation systems. Additionally, strong reimbursement support and access to specialized orthopedic surgeons reinforce hospitals’ dominant role in trauma care.
   
• The ambulatory surgical centers segment held a revenue of USD 842.3 million in 2024, with projections indicating a steady expansion at 3.9% CAGR from 2025 to 2034. The segmental growth is driven by offering cost-effective, same-day fracture repair procedures. Their shorter recovery times, lower infection risks, and high patient satisfaction make them an attractive alternative to hospitals. The increasing shift of orthopedic procedures to ASCs is boosting demand for trauma fixation devices tailored to outpatient settings.
   

South Atlantic Trauma Fixation Devices Market

South Atlantic dominated the U.S. trauma fixation devices market with the highest market share of 20.8% in 2024.
 

• The South Atlantic has one of the largest elderly populations in the U.S., especially in Florida and the Carolinas. Older adults are more prone to fractures caused by osteoporosis and falls, creating strong demand for trauma fixation devices. This demographic factor makes the region a hotspot for orthopedic procedures.
   
• With a dense population, extensive road networks, and a strong culture of outdoor activities like boating, hiking, and sports, the South Atlantic reports a high number of trauma cases. These injuries frequently involve lower and upper extremity fractures that require fixation devices. The lifestyle-driven injury burden sustains market demand.
   
• Further, the advanced trauma centers and orthopedic research centers located in the South Atlantic states, such as Duke University Hospital in North Carolina and those in Virginia and Florida, make the region a core adopter of trauma fixation and minimally invasive surgery. These centers are early adopters of advanced trauma fixation devices, which accelerates market penetration of novel products.
   

Northeast Trauma Fixation Devices Market

Northeast trauma fixation devices industry accounted for USD 802.6 million in 2024 and is anticipated to show lucrative growth over the forecast period.
 

• The Northeast region of the U.S. has one of the highest population densities, particularly in metropolitan areas such as New York, Boston, and Philadelphia. According to the U.S. Census Bureau (2023), the Northeast region's population density is 363.3 people per square mile, significantly higher than the national average of 93.8 people per square mile.
   
• The National Highway Traffic Safety Administration (NHTSA) reported 7,262 traffic fatalities in the Northeast region in 2022, a 12% increase from 2021. The Bureau of Labor Statistics documented 235,740 workplace injuries in the Northeast region in 2023, with 42% requiring medical intervention through trauma fixation procedures. These factors contribute to a higher incidence of traumatic injuries, driving the demand for trauma fixation devices in the region.
   
• Additionally, the region is home to leading institutions like Massachusetts General Hospital, Hospital for Special Surgery, and Penn Medicine. These centers conduct advanced orthopedic research and perform a large volume of trauma surgeries. Their emphasis on innovation accelerates the adoption of next-generation fixation devices in clinical practice.
   

Pacific Central Trauma Fixation Devices Market

The Pacific Central trauma fixation devices industry is anticipated to grow at the highest CAGR of 3.6% during the analysis timeframe.
 

• California alone accounts for nearly 12% of the U.S. population, creating a massive healthcare demand. The large and diverse population leads to a higher absolute number of trauma cases, from both accidental injuries and age-related fractures. This demographic scale is a major growth driver for fixation device usage.
   
• Urban congestion in cities like Los Angeles, San Francisco, and Seattle results in high numbers of vehicle-related accidents. These incidents often involve severe fractures requiring surgical intervention with internal or external fixators. The traffic-related trauma burden sustains demand for fixation devices in the region.
   
• Further, the Pacific Central region has witnessed rapid expansion of outpatient and ambulatory surgical centers, especially in California and Washington. Many trauma fixation procedures are increasingly performed in these settings due to cost savings and patient convenience. This shift enhances accessibility and boosts market adoption of trauma fixation devices.
   

U.S. Trauma Fixation Devices Market Share

The U.S. trauma fixation devices industry is highly competitive, characterized by a mix of global leaders and mid-sized companies focusing on innovation and specialization. Market competition is driven by product differentiation, technological advancements, and the ability to cater to both hospital and outpatient surgical settings.
 

Key players include Johnson & Johnson, Stryker, Smith+Nephew, Zimmer Biomet, and INTEGRA, collectively accounting for 74.8% of the total market share. These companies leverage strong distribution networks, R&D investments, and strategic partnerships to maintain dominance.
 

Similarly, smaller players and emerging companies are carving out niches by developing cost-effective and customized fixation solutions, including bioabsorbable implants and modular external fixators. The competitive intensity is further heightened by frequent mergers, acquisitions, and collaborations aimed at portfolio expansion and faster regulatory approvals.
 

This dynamic landscape ensures continuous innovation while also placing pricing pressure on established players to remain competitive in a rapidly evolving U.S. healthcare environment.
 

U.S. Trauma Fixation Devices Market Companies

Few of the prominent players operating in the U.S. trauma fixation devices industry include:

• Acumed
• Arthrex
• B. Braun
• Bioretec
• Citieffe
• CONMED
• Implanet
• INTEGRA
• Johnson & Johnson
• KLS Martin Group
• Medicon
• ORTHOFIX
• Smith+Nephew
• Stryker
• Zimmer Biomet
   
• Johnson & Johnson

Johnson & Johnson (DePuy Synthes), leading the U.S. trauma fixation devices market with a 26.3% share in 2024, offers the broadest trauma fixation portfolio in the U.S., covering plates, screws, nails, and external fixation systems. Its integration with J&J’s global R&D and distribution network ensures advanced innovation and strong market penetration.
 

• Stryker

Recognized for leadership in intramedullary nailing systems and innovation-driven product development. Its focus on surgeon training, robotics integration, and patient-centric solutions strengthens adoption across both hospitals and ASCs.
 

• Smith+Nephew

Differentiates itself through strong expertise in upper and lower extremity fixation devices, with a focus on minimally invasive solutions. Its global reach combined with advanced technologies supports high surgeon confidence and competitive positioning in the U.S. market.
 

U.S. Trauma Fixation Devices Industry News:

• In October 2024, Johnson & Johnson launched the first phase of the VOLT Variable Angle Optimized Locking Technology Plating System, an advanced solution aimed at improving stability, performance, and efficiency in fracture management. The system enhanced surgical precision and treatment outcomes. This launch expanded the company’s trauma fixation portfolio and reinforced its leadership in the U.S. market.
   
• In October 2023, Johnson & Johnson received 510(k) FDA approval for its TriALTIS spine system and TriALTIS navigation-enabled instruments, a next-generation pedicle screw platform with advanced implants and instrumentation. The system allowed both navigated and non-navigated applications, improving surgical precision and flexibility. This approval strengthened the company’s U.S. trauma fixation portfolio, enhancing competitiveness through innovation and technology integration.
   
• In September 2023, Orthofix Medical Inc. introduced the Galaxy Fixation Gemini system in the U.S. and completed its first successful cases. The device was offered in sterile kit configurations, providing a rapid off-the-shelf option for upper and lower limb fractures. This launch strengthened the company’s trauma fixation portfolio and enhanced its presence in the U.S. market.
   

The U.S. trauma fixation devices market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 - 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Product

• Internal fixators
  • Plates
  • Nails
  • Screws
  • Other internal fixators
• External fixators
  • Unilateral and bilateral
  • Hybrid
  • Circular

Market, By Material

• Stainless steel
• Titanium
• Other materials

Market, By Site

• Lower extremities
  • Foot & ankle
  • Knee
  • Lower leg
  • Hip and pelvic
  • Thigh
• Upper extremities
  • Arm
  • Hand & wrist
  • Shoulder
  • Elbow

Market, By End Use

• Orthopedic centers
• Hospitals
• Ambulatory surgical centers
• Other end use

The above information is provided for the following zones and states:

• East North Central
  • Illinois
  • Indiana
  • Michigan
  • Ohio
  • Wisconsin
• West South Central
  • Arkansas
  • Louisiana
  • Oklahoma
  • Texas
• South Atlantic
  • Delaware
  • Florida
  • Georgia
  • Maryland
  • North Carolina
  • South Carolina
  • Virginia
  • West Virginia
  • Washington, D.C.
• Northeast
  • Connecticut
  • Maine
  • Massachusetts
  • New Hampshire
  • Rhode Island
  • Vermont
  • New Jersey
  • New York
  • Pennsylvania
• East South Central
  • Alabama
  • Kentucky
  • Mississippi
  • Tennessee
• West North Centra
  • Iowa
  • Kansas
  • Minnesota
  • Missouri
  • Nebraska
  • North Dakota
  • South Dakota
• Pacific Central
  • Alaska
  • California
  • Hawaii
  • Oregon
  • Washington
• Mountain States
  • Arizona
  • Colorado
  • Utah
  • Nevada
  • New Mexico
  • Idaho
  • Montana
  • Wyoming